FeesSafety
Pluang+

Structure Therapeutics to present at Jefferies Global Healthcare Conference in London Nov 17

Market News
04 Nov 2026, 14:30 WIB
GlobeNewsWire
View Source
Neutral
Structure Therapeutics to present at Jefferies Global Healthcare Conference in London Nov 17

Structure Therapeutics, a clinical-stage biopharmaceutical company focused on oral treatments for metabolic diseases like obesity, will participate in the Jefferies Global Healthcare Conference in London on November 17, 2026. The company will engage in a fireside chat and one-on-one meetings, with live and archived webcasts available on their website. This event highlights their ongoing efforts to advance innovative small molecule therapies targeting chronic weight management, aiming to offer scalable and accessible options beyond traditional biologics. Investors and interested parties can follow the presentations online for insights into their latest developments.

Structure Therapeutics' participation in the Jefferies Global Healthcare Conference provides context for health-sector market activity. As of Nov 04, 2026 18:41 WIB, 118 of 150 priced health-sector US stocks on Pluang rose while 24 fell. Notable movers include Tenet Healthcare Corporation at USD 279.75 with a 4.90% increase and Abeona Therapeutics Inc at USD 4.41 with 100% buy order activity.

More News

KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings to release Q3 2026 financial results on Nov 16 with a live earnings call.

KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...

Company Fundamentals
Neutral
2 hours ago
JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com to release Q3 2026 financial results on Nov 17 with a management call scheduled.

JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...

Company Fundamentals
Neutral
2 hours ago
Dimensional Fund Advisors discloses 1.27% stake in Prologis Inc as of Nov 3, 2026

Dimensional Fund Advisors discloses 1.27% stake in Prologis Inc as of Nov 3, 2026

Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc as of November 3, 2026. This disclosure is part of regulatory requirements under the Takeover Code for investors holding 1% or more in relevan...

Market News
Neutral
2 hours ago
Dimensional Fund Advisors discloses 1.78% stake in DCC Energy shares as of Nov 2026

Dimensional Fund Advisors discloses 1.78% stake in DCC Energy shares as of Nov 2026

Dimensional Fund Advisors Ltd. has disclosed an interest in 1,516,595 ordinary shares of DCC Energy plc, representing 1.78% of the company's shares as of November 3, 2026. The disclosure follows regulatory requirements under the Irish Takeover Panel ...

Market News
Neutral
2 hours ago
reUSD launches on Monad, enabling cross-chain reinsurance yield access with new DeFi options.

reUSD launches on Monad, enabling cross-chain reinsurance yield access with new DeFi options.

reUSD is now available on the Monad blockchain, allowing users to access tokenized reinsurance yields beyond Ethereum. Users can bridge reUSD from Ethereum to Monad via Chainlink CCIP and engage with markets on Morpho and Pendle. On Monad, users can ...

Protocol Fundamentals
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App